Your browser doesn't support javascript.
loading
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML).
Kessler, Torsten; Koschmieder, Steffen; Schliemann, Christoph; Crysandt, Martina; Mikesch, Jan-Henrik; von Stillfried, Saskia; Stelljes, Matthias; Pohlen, Michele; Lenz, Georg; Kirsch, Anna; Vehring, Kerstin; Wardelmann, Eva; Hartmann, Wolfgang; Bormann, Eike; Gerss, Joachim; Brümmendorf, Tim H; Müller-Tidow, Carsten; Berdel, Wolfgang E.
  • Kessler T; Department of Medicine A, University Hospital Muenster, Muenster, Germany. torstenkessler@uni-muenster.de.
  • Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany. skoschmieder@ukaachen.de.
  • Schliemann C; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • Crysandt M; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Mikesch JH; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • von Stillfried S; Institute for Pathology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Stelljes M; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • Pohlen M; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • Lenz G; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • Kirsch A; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • Vehring K; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • Wardelmann E; Gerhard-Domagk-Institute for Pathology, University Hospital Muenster, Muenster, Germany.
  • Hartmann W; Gerhard-Domagk-Institute for Pathology, University Hospital Muenster, Muenster, Germany.
  • Bormann E; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Gerss J; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Müller-Tidow C; Department of Medicine A, University Hospital Muenster, Muenster, Germany.
  • Berdel WE; Department of Medicine V, University of Heidelberg, Heidelberg, Germany.
Ann Hematol ; 98(6): 1393-1401, 2019 Jun.
Article en En | MEDLINE | ID: mdl-30903275
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Leucemia Mieloide Aguda / Inhibidores de la Angiogénesis / Inhibidores de Proteínas Quinasas / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Leucemia Mieloide Aguda / Inhibidores de la Angiogénesis / Inhibidores de Proteínas Quinasas / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article